Company Profile

Tactile Systems Technology, Inc. Stock Price, News & Analysis

Ticker:
TCMD
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

28.86 USD (-3.74%)

Close

Last updated: August 6, 2026

551M USD

Market cap

Why the stock is moving

As of Aug 6, 2026, TCMD closed down 3.74% at $28.86. No new same-company headline was identified in the current news window.

Company overview

Business overview

Tactile Systems Technology is a medical device company focused on airway clearance and lymphedema treatment solutions. Its business is centered on specialty devices for chronic-care patients.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Tactile sits in specialty medtech.

Business Model Characteristics

The company generates revenue from device sales, patient adoption, and recurring use in chronic respiratory and lymphatic care.

Position Within the Biotechnology Landscape

Tactile Systems is a niche medtech name that trades on adoption and product execution rather than biotech catalysts.

Future catalysts

Tactile Medical is still a product-therapy company at heart, with Flexitouch and its related chronic-disorder therapies doing the heavy lifting. The important thing now is whether those therapies keep building enough routine use to make the commercial base feel steadier.

Recent news

  1. 01
  2. 02
  3. 03

    Tactile Medical Launches Next-Generation AffloVest® Airway Clearance Therapy

    Source: Tactile Systems Technology, Inc.

  4. 04

    Tactile Medical to Present at the William Blair 46th Annual Growth Stock Conference

    Source: Tactile Systems Technology, Inc.

  5. 05

    Tactile Systems Technology, Inc. Reports First Quarter 2026 Financial Results

    Source: Tactile Systems Technology, Inc.

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Tactile Systems Technology, Inc. (TCMD)?

Tactile Systems Technology, Inc. (TCMD) most recently closed at 28.86 USD, a -3.74% move versus the previous session.

What is the market cap of Tactile Systems Technology, Inc. (TCMD)?

Tactile Systems Technology, Inc. currently has a market capitalization of 551M USD on BioPharmSignal.

What does Tactile Systems Technology, Inc. do?

Tactile Systems Technology is a medical device company focused on airway clearance and lymphedema treatment solutions. Its business is centered on specialty devices for chronic-care patients.

On which exchange is TCMD stock listed?

Tactile Systems Technology, Inc. (TCMD) is associated with NASDAQ, United States, Biopharma.

What is Tactile?

Tactile Medical is still a product-therapy company at heart, with Flexitouch and its related chronic-disorder therapies doing the heavy lifting.

Which conditions is Tactile Systems Technology, Inc. targeting with Tactile?

Tactile Medical is still a product-therapy company at heart, with Flexitouch and its related chronic-disorder therapies doing the heavy lifting.

How does Tactile Systems Technology, Inc. describe recent progress with Tactile?

Tactile Medical is still a product-therapy company at heart, with Flexitouch and its related chronic-disorder therapies doing the heavy lifting.

What is Systems?

Tactile Systems Technology is a medical device company focused on airway clearance and lymphedema treatment solutions.